REMEVi's bilingual GLP-1 program works in 3 steps: complete a 5-minute online intake in English or Spanish, a US-licensed provider reviews your case within 24 hours, and your compounded medication ships from an FDA-registered pharmacy to your door in 5–7 business days. Available in all 50 states + DC.
The Process
Step 1
5 minutesComplete a short, private intake form in English or Spanish. No phone call required. We ask about your health history, goals, current medications, and eligibility. Your answers are encrypted and HIPAA-protected.
Step 2
Within 24 hoursA licensed US provider reviews your intake information and creates your personalized treatment plan. They check your eligibility, review any contraindications, and prescribe the most appropriate medication and dosage for your goals.
Step 3
5–7 business daysYour prescription is sent directly to an FDA-registered US compounding pharmacy. Your medication is prepared and shipped in discreet, unmarked packaging — directly to your door, no pharmacy trips required.
Step 4
Throughout your programYou are never on your own. Your bilingual care coordinator is available throughout your program to answer questions, adjust your dose, and support your progress. In English or Spanish, within 2 hours.
Every step 2 review is done by a board-certified US licensed provider. Meet the REMEVi care team →
Bilingual care team, WhatsApp-first, progress at a glance. This is an example view — your actual dashboard opens after a REMEVi provider approves your protocol.
Patient Safety
We know trusting a new provider isn't easy. Here's how we earn that trust.
REMEVi is LegitScript certified — the same verification required by Google, Meta, and TikTok. Your medication comes from an FDA-registered US compounding pharmacy, and your data is protected by HIPAA-certified infrastructure with zero breaches.
If our licensed provider determines you're not a good candidate, there is no charge. If you start treatment and need adjustments, dosage changes are included in your plan at no extra cost. Cancel anytime — no fees.
The most common side effects — nausea and mild GI discomfort — are temporary and typically resolve within 2-4 weeks. Your care coordinator monitors your progress and adjusts dosage as needed.
See full side effects info →Every REMEVi prescription is reviewed and approved by a board-certified US licensed provider authorized to practice in your state. No AI prescribing. Every prescription is reviewed by a licensed provider — an MD or nurse practitioner — authorized to practice in your state.
Meet our medical team →Your bilingual care coordinator responds within 2 hours. For severe symptoms, we provide clear escalation guidance — including when to contact emergency services. You are never on your own.
Reviews
"Great experience overall. Professional, reliable, and very easy to work with. I also really appreciated that they offer customer service in Spanish, which made communication smooth and comfortable."
"Highly recommend their services, fast, efficient, and have had a great experience. Much more reasonably priced than the office my mom was seeing."
"Easy to use interface and started seeing results sooner than expected. I wish knew sooner how easy it could be. Thank you REMEVi Health."
1 of 10
Same price every month for the length of your plan. No "first-month special." No surprise increases. The price you see is the price you pay — for as long as you are a patient.
Provider-managed weekly injection. The same compounded GLP-1 as the big-brand competitors — with bilingual care, no insurance, no surprise increases.
Daily oral semaglutide. Same clinical oversight, same bilingual care — without the needle.
Dual-agonist tirzepatide. The strongest average loss in the GLP-1 category — provider-managed, bilingual care.
¹ Clinical-trial results for semaglutide (STEP-1, NEJM 2021) and tirzepatide (SURMOUNT-1, NEJM 2022) — the active medications in REMEVi protocols, not REMEVi outcomes or guarantees. Compounded preparations are not FDA-approved and have not been studied as finished products. Individual results vary.
REMEVi's semaglutide is compounded by a 503B outsourcing facility registered with the FDA — the same regulatory tier hospitals use. Compounded medications are not FDA-approved finished drug products; they are prepared under the 503A or 503B framework to USP <797> sterility standards and prescribed by a licensed provider in your state who will review the risks, benefits, and considerations with you.
Most patients receive their first medication within 7 business days of completing the intake form.
Start Free ConsultFAQ
Most clinical reviews are completed within 24 hours of submitting your intake form. Some are completed within 2-4 hours. You will receive an email notification as soon as your licensed provider has reviewed your case and made a prescribing decision.
Yes - REMEVi is fully bilingual. You can complete your intake form, receive your clinical evaluation, and communicate with your care coordinator entirely in Spanish.
No. REMEVi is an out-of-pocket telehealth service. No insurance is required, and no information is shared with insurance companies. Your visit is private between you and your licensed provider.
All medications ship in plain, unmarked packaging with no indication of contents on the outside. Your billing statement shows REMEVi LLC only. Tracking is provided via email so you can monitor delivery.
Yes - you can cancel or pause your program at any time with no cancellation fees. Simply log into your patient portal or contact your care coordinator.
If your licensed provider determines that medication is not appropriate for you, there is no charge. You will receive a detailed explanation of why, along with alternative recommendations if relevant.
No insurance required · Cancel anytime
